It also addresses the FDA’s communications Using the applicant, the retention of data that assistance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of the SE report back to a brand new applicant and electronic submission of your SE report and amendme